We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+7.28%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.08%
AUM
$42.5B
AUM Growth
+$2.36B
(+5.9%)
Cap. Flow
-$129M
Cap. Flow
% of AUM
-0.3%
Top 10 Holdings %
Top 10 Hldgs %
33.33%
Holding
1,050
New
87
Increased
310
Reduced
398
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$78.2M |
| 2 |
Amazon
AMZN
|
+$74.6M |
| 3 |
Cisco
CSCO
|
+$69.3M |
| 4 |
Monster Beverage
MNST
|
+$68.9M |
| 5 |
Oracle
ORCL
|
+$67.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$449M |
| 2 |
AGN.PRA
Allergan plc
AGN.PRA
|
+$175M |
| 3 |
AutoZone
AZO
|
+$87M |
| 4 |
Varex Imaging
VREX
|
+$49M |
| 5 |
CVS Health
CVS
|
+$44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.75% |
| 2 | Consumer Discretionary | 15.19% |
| 3 | Healthcare | 12.92% |
| 4 | Financials | 12.83% |
| 5 | Communication Services | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WDR
601
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $38K | ﹤0.01% |
1,987
+1,615
| +434% | +$28.4K |
|
|
TECD
602
DELISTED
Tech Data Corp
TECD
| $38K | ﹤0.01% |
373
+218
| +141% | +$21K |
|
603
Emergent Biosolutions
EBS
$382M
| $37K | ﹤0.01% |
1,087
+209
| +24% | +$6.45K |
|
604
The Greenbrier Companies
GBX
$1.56B
| $37K | ﹤0.01% |
799
+31
| +4% | +$1.41K |
|
605
NVIDIA
NVDA
$5.13T
| $37K | ﹤0.01% |
10,240
-213,640
| -95% | -$679K |
|
|
CBM
606
DELISTED
Cambrex Corporation
CBM
| $37K | ﹤0.01% |
627
+17
| +3% | +$955 |
|
607
Dolby
DLB
$5.59B
| $36K | ﹤0.01% |
738
-15,338
| -95% | -$782K |
|
608
Moelis & Co
MC
$5.08B
| $36K | ﹤0.01% |
917
+39
| +4% | +$1.45K |
|
|
AVTA
609
DELISTED
Avantax, Inc. Common Stock
AVTA
| $36K | ﹤0.01% |
1,707
+687
| +67% | +$13.6K |
|
|
LMNX
610
DELISTED
Luminex Corp
LMNX
| $36K | ﹤0.01% |
1,697
+39
| +2% | +$781 |
|
|
CHSP
611
DELISTED
Chesapeake Lodging Trust
CHSP
| $36K | ﹤0.01% |
1,487
+1,327
| +829% | +$31.7K |
|
|
FBC
612
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $36K | ﹤0.01% |
1,181
-12
| -1% | -$354 |
|
613
Ennis
EBF
$558M
| $35K | ﹤0.01% |
1,812
+394
| +28% | +$6.63K |
|
614
Progress Software
PRGS
$1.7B
| $35K | ﹤0.01% |
1,140
+745
| +189% | +$22.1K |
|
615
Stepan Co
SCL
$1.44B
| $35K | ﹤0.01% |
401
-7
| -2% | -$589 |
|
616
TTM Technologies
TTMI
$13.8B
| $35K | ﹤0.01% |
2,010
-144
| -7% | -$2.42K |
|
617
Wabash National
WNC
$508M
| $35K | ﹤0.01% |
1,597
-49
| -3% | -$1.03K |
|
|
NXGN
618
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $35K | ﹤0.01% |
2,009
+244
| +14% | +$3.71K |
|
|
AVX
619
DELISTED
AVX Corporation
AVX
| $35K | ﹤0.01% |
2,136
+415
| +24% | +$6.85K |
|
|
GTLS
620
DELISTED
Chart Industries
GTLS
| $34K | ﹤0.01% |
981
+85
| +9% | +$2.96K |
|
621
Omnicell
OMCL
$1.71B
| $34K | ﹤0.01% |
800
-65
| -8% | -$2.7K |
|
622
Southwest Gas
SWX
$6.5B
| $34K | ﹤0.01% |
462
+56
| +14% | +$4.48K |
|
|
SYNH
623
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $34K | ﹤0.01% |
589
-89
| -13% | -$4.63K |
|
|
FLIR
624
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $34K | ﹤0.01% |
977
-186,782
| -99% | -$6.81M |
|
|
ARII
625
DELISTED
American Railcar Industries, Inc.
ARII
| $34K | ﹤0.01% |
880
+195
| +28% | +$7.52K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2017 Portfolio in Review
As of Q2 2017, Loomis, Sayles & Company held 1,050 positions worth $42.5B, up 5.9% from $40.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Loomis, Sayles & Company's Q2 2017 filing shows 87 new, 310 increased, 398 reduced and 100 closed positions. Its largest new stake was Danaher: 762,466 shares worth $57M. The largest sale was Intel, an estimated $449M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Loomis, Sayles & Company's largest Q2 2017 buy was Danaher: 762,466 shares worth $57M.
- Loomis, Sayles & Company added most to Visa in Q2 2017, an estimated $78.2M increase.
- Loomis, Sayles & Company's biggest Q2 2017 reduction was Allergan plc, cutting an estimated $175M.
- Loomis, Sayles & Company fully exited Intel in Q2 2017, selling an estimated $449M.
- Loomis, Sayles & Company's ten largest holdings make up 33% of its $42.5B portfolio in Q2 2017.
- Loomis, Sayles & Company opened 87 new positions and closed 100 in Q2 2017.
- Loomis, Sayles & Company's portfolio value rose 5.9% quarter-over-quarter to $42.5B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2017, filed 14 Aug 2017.